Vivani Medical Q1 2026 Earnings Slight EPS Beat Signals Progress Despite No Revenue PharmaCyte Biotech PMCB Q1 2026 Earnings Narrowing Loss Amid Strategic Pipeline Progress REVB Q1 2026 Earnings Significant EPS Miss as PreRevenue Biotech Reports Operating Loss Extreme Networks EXTR Q1 2026 Earnings EPS Beat Drives 745 Stock Rally SEDG Q1 2026 Earnings WiderThanExpected Loss Amidst Ongoing Industry Headwinds DarioHealth Holds Steady at 77 Consolidation Near Resistance in a Flat Session Snail Inc SNAL Retreats to 092 as Selling Pressure Intensifies KKR Real Estate Finance Trust KREF Gains 14 as Real Estate Lending Stabilizes LB Pharmaceuticals Inc LBRX Edges Higher Amid Sector Strength Key Levels in Focus Exagen Inc XGN Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Surprise